Esomeprazole Tablets 20 mg Exporter in India – Healthy Inc

Esomeprazole Tablets 20 mg | Exporter
Product image for Esomeprazole Tablets 20 mg Exporter; regulatory dossiers & international shipping.
Product Information
| Generic Name | Esomeprazole |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | IP / BP |
| Product Type | Tablet |
| Category | Gastrointestinal drugs – Acid Suppression |
| Subcategory | Acid Suppression |
| Active Ingredient | Esomeprazole |
| Strength | 20 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Gastrointestinal drugs – Acid Suppression |
Medicine Details & Safety
| Short Description | Healthy Inc invites international procurement enquiries for Esomeprazole Tablets 20 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Symptomatic relief and healing of erosive gastroesophageal reflux disease (GERD). 2. Treatment of gastric ulcers, duodenal ulcers, and NSAID-associated mucosal injury. | ||||||||||||||||||||||||
| Full Description | Healthy Inc invites international procurement enquiries for Esomeprazole Tablets 20 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. Product technical specifications
Product technical specifications
Export regulatory and dossier readinessIdentify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.Climatic zone stability and export artworkFor Esomeprazole Tablets 20 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.Global logistics and trade termsSpecify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.International buyer requirementsEnquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally 30 to 60 minutes before morning meals (or as prescribed for antacids, after meals and at bedtime). Swallow whole with water; do not crush or chew enteric-coated tablets. | ||||||||||||||||||||||||
| Side Effects | Common: Headache, diarrhea, constipation, abdominal discomfort, nausea. Uncommon: Flatulence, dry mouth, dizziness, transient transaminase elevation. Rare: Hypomagnesemia, Clostridioides difficile-associated diarrhea, subacute cutaneous lupus. | ||||||||||||||||||||||||
| Warnings and Precautions | Masking Malignancy: Symptomatic relief does not preclude presence of gastric malignancy; perform diagnostic workup if alarm symptoms exist. Long-Term Bone Density: Extended chronic use may slightly elevate risk of osteoporosis-related fractures; ensure adequate calcium and vitamin D intake. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Esomeprazole or substituted benzimidazoles / antacids. 2. Severe electrolyte imbalances (for magnesium/aluminum antacids in renal failure). 3. Concurrent administration with rilpivirine-containing products. | ||||||||||||||||||||||||
| Drug Interactions | 1. pH-Dependent Bioavailability Drugs (Ketoconazole, Itraconazole, Iron Salts): Reduced absorption due to elevated gastric pH. 2. Clopidogrel: Potential attenuation of antiplatelet activation by certain proton pump inhibitors. 3. Digoxin & Methotrexate: Elevated serum concentrations requiring dosage monitoring. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Which registration documents can be requested for Esomeprazole Tablets 20 mg? | Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review. |
| Is Zone IVb data available for Esomeprazole Tablets 20 mg? | Request confirmation for the exact formulation and packaging configuration. |
| Can export artwork be multilingual for Esomeprazole Tablets 20 mg? | Provide the required languages and approved regulatory artwork for review. |
| Which shipping terms can be discussed for Esomeprazole Tablets 20 mg? | EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement. |
| How do I obtain an export quotation for Esomeprazole Tablets 20 mg? | Provide destination country, quantity, documentation requirements and preferred trade terms. |
Related Products
✚
Esomeprazole Tablets 20 mg ManufacturerView product →
✚
Esomeprazole Tablets 20 mg SupplierView product →
✚
Esomeprazole Tablets 40 mg ExporterView product →
✚
Esomeprazole Tablets 40 mg ManufacturerView product →
✚
Esomeprazole Tablets 40 mg SupplierView product →
✚
Cimetidine Tablets USP 200 mg ExporterView product →
✚
Cimetidine Tablets USP 200 mg ManufacturerView product →
✚
Cimetidine Tablets USP 200 mg SupplierView product →
✚
Cimetidine Tablets USP 400 mg ExporterView product →
✚
Cimetidine Tablets USP 400 mg ManufacturerView product →
✚
Cimetidine Tablets USP 400 mg SupplierView product →
✚
Famotidine Tablets USP 20 mg ExporterView product →
